Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt Preliminary FY2021 Revenues Down 65 Percent Amid Supply Contract Dispute

NEW YORK — Novacyt said on Tuesday that its preliminary revenues for full-year 2021 were down 65 percent as a COVID-19 product supply dispute with the UK Department of Health and Social Care continues.

The French diagnostics firm also warned that its COVID-19 sales could be cut in half in 2022, a decline it hopes to offset with new non-COVID-19 offerings.

Novacyt reported preliminary 2021 revenues of £95.8 million ($129.0 million), down from £277.2 million the year before. The 2021 revenue figures do not include £40.8 million in COVID-19 product revenues from the DHSC, which is currently seeking a refund for certain products supplied by the company.

For 2021, revenues from COVID-19 products accounted for 86 percent of total revenues, compared with 95 percent in 2020, Novacyt said. At the end of 2021, the firm had £101.8 million in cash.

Citing the unpredictability of the SARS-CoV-2 pandemic, Novacyt said that it expects COVID-19 reported sales could be as much as 50 percent lower in 2022 versus 2021, but that this drop will be partially offset by non-COVID-19 products sales beginning in the fourth quarter of this year.

"We remain committed to becoming a leading, global clinical diagnostics company in the fight against infectious diseases … [and] endeavor to streamline our R&D program to ensure we are keenly focused on commercially attractive opportunities and bringing the right solutions, to the right customers at the right time," Novacyt CEO David Allmond said in a statement. "We will also reevaluate how we leverage our products in each of our target global markets as we continue on our path of international expansion."

In September, Novacyt posted a nearly 15 percent drop in revenues for the first half of 2021.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.